Stay updated on Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.

Latest updates to the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now displays revision v3.6.3, replacing the previous revision v3.6.1. This indicates a version update to the page, likely reflecting minor edits or corrections rather than substantive changes to study information.SummaryDifference0.0%

- Check17 days agoChange DetectedThe page's Revision tag changed from v3.6.0 to v3.6.1, signaling a minor version update to the page metadata.SummaryDifference0.0%

- Check26 days agoChange DetectedNew help and navigation sections were added to improve reader access to study information, including How to Read a Study Record, Common Questions, and How to Join a Study. The page now shows an updated revision tag (Revision: v3.6.0) and standardizes the Intervention/Treatment label, replacing the previous Interventions / Treatment formatting and removing the older revision tag.SummaryDifference0.2%

- Check33 days agoChange Detected- Revision updated from v3.5.4 to v3.5.5, indicating a small metadata update to the page.SummaryDifference0.0%

- Check47 days agoChange DetectedNew update dates were added (2026-05-21 and 2026-05-22) and older dates (2026-05-12, 2026-05-13, and 2025-11) were removed from the Study Record Dates, reflecting recent administrative updates to the page.SummaryDifference0.1%

- Check54 days agoChange DetectedA new Sample Collection section was added to the study plan, and the record was updated to revision v3.5.4, signaling changes in how specimens are collected and documented for the trial.SummaryDifference0.2%

Stay in the know with updates to Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.